Shaimaa E. Ghany-Abdel

Giza, GZ 12566, Egypt

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Targeted Folate-Chitosan Nanoformulations of Quercetin and Coriandrum sativum Reprogram Breast Cancer Hallmarks by Silencing Stemness, Cell Cycle, Angiogenic, and Metastatic Networks.

Targeted Folate-Chitosan Nanoformulations of Quercetin and Coriandrum sativum Reprogram Breast Cancer Hallmarks by Silencing Stemness, Cell Cycle, Angiogenic, and Metastatic Networks.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 29, 2026

Circadian rhythms as orchestrators of breast cancer metastasis: From molecular mechanisms to chronotherapeutic interventions.

Circadian rhythms as orchestrators of breast cancer metastasis: From molecular mechanisms to chronotherapeutic interventions.

Journal: Cancer letters
Published: April 27, 2026

Mechanisms of Resistance and Synergy: The Role of Tumor Microenvironment in HER2-Low Breast Cancer Therapy.

Mechanisms of Resistance and Synergy: The Role of Tumor Microenvironment in HER2-Low Breast Cancer Therapy.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 24, 2026

Mapping Non-Coding Epimutations in Breast Cancer: Advancing Epigenetics Towards Precision Medicine.

Mapping Non-Coding Epimutations in Breast Cancer: Advancing Epigenetics Towards Precision Medicine.

Journal: Sub-cellular biochemistry
Published: January 01, 2026

Integrating multi-omics and artificial intelligence for personalized breast cancer management: A guide to clinicians.

Integrating multi-omics and artificial intelligence for personalized breast cancer management: A guide to clinicians.

Journal: Cancer letters
Published: December 26, 2025

The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications.

The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 24, 2025

Antibody-Drug Conjugates in Breast Cancer: Navigating Innovations, Overcoming Resistance, and Shaping Future Therapies.

Antibody-Drug Conjugates in Breast Cancer: Navigating Innovations, Overcoming Resistance, and Shaping Future Therapies.

Journal: Biomedicines
Published: July 11, 2025

Cancer-associated adipocytes: metabolic reprogramming, crosstalk and therapeutic implications in tumor progression.

Cancer-associated adipocytes: metabolic reprogramming, crosstalk and therapeutic implications in tumor progression.

Journal: Signal transduction and targeted therapy
Published: July 03, 2025

Targeting Resistance Pathways in Breast Cancer Through Precision Oncology: Nanotechnology and Immune Modulation Approaches.

Targeting Resistance Pathways in Breast Cancer Through Precision Oncology: Nanotechnology and Immune Modulation Approaches.

Journal: Biomedicines
Published: June 21, 2025

Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges.

Bridging the Gap in Breast Cancer Dormancy: Models, Mechanisms, and Translational Challenges.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 07, 2025

Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.

Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 27, 2025

Correction: Vitamin D: a key player in COVID‑19 immunity and lessons from the pandemic to combat immune‑evasive variants.

Correction: Vitamin D: a key player in COVID‑19 immunity and lessons from the pandemic to combat immune‑evasive variants.

Journal: Inflammopharmacology
Published: April 11, 2025
Showing 1-12 of 44

Last Updated: 09/26/2026